NE NEWS SERVICE
AHMEDABAD, JULY 19
A serological survey of around 5,000 people from different parts of Ahmedabad city has revealed that 81.63 percent of the sampled population had developed antibodies against COVID-19, officials said on Monday.
Co-Win પોર્ટલ પર નોંધાયેલા લાભાર્થીઓનો ડેટા બિલકુલ સલામત છે: ડૉ. આર.એસ. શર્મા, મુખ્ય કાર્યકારી અધિકારી, રાષ્ટ્રીય સ્વાસ્થ્ય પ્રાધિકરણ #COVIDGuruKool #Unite2FightCorona @MoHFW_INDIA @GujHFWDept pic.twitter.com/syXva4o5HT
— PIB in Gujarat 🇮🇳 (@PIBAhmedabad) July 19, 2021
People who have taken both doses of coronavirus vaccines had high levels of seropositivity as compared to those who were yet to be inoculated, they said, citing findings of the recent survey.
સાવચેતી અને સમજાદારીથી રહેશે દૂર કોરોનાની બીમારી
કોવિડ અનુરૂપ વ્યવહારોનું ચુસ્તપણે નિયમિત પાલન તમને સંક્રમણથી રાખશે સલામત@MoHFW_INDIA @CMOGuj @PIBAhmedabad @ROBgujarat @JpShivahare @DrNilamPatel04 @AmdavadAMC @smartcityrajkot @VMCVadodara @MySuratMySMC pic.twitter.com/aDRSZ6RN62
— GujHFWDept (@GujHFWDept) July 19, 2021
The survey to detect seropositivity for antibodies against SARS-CoV2, which causes COVID-19, was conducted by the Ahmedabad Municipal Corporation (AMC) between May 28 and June 3, when the second wave of the pandemic was subsiding.
Seropositivity essentially means the presence of antibodies in the blood serum.
Ensuring zero deaths due to Diarrhoeal disease.
Let us join hands during a IDCF campaign
(19th July to 2nd Aug 2021)
🙏No child with #Diarrhoea left without treatment with ORS & Zinc.
#WeCare #preventdiarrhea@MoHFW_INDIA @JpShivahare @UnicefIndia @WHO @UNDP @NutritionIntl pic.twitter.com/KiUXATGatR— NHM Gujarat (@NHMGujarat) July 19, 2021
“We carry out serosurveillance studies at regular intervals to detect antibodies. Overall, 80 per cent seropositivity has been detected in the general population of Ahmedabad. Those who took both the doses had high levels of seropositivity as compared to those who took none,” said AMC Medical Officer of Health Dr Bhavin Solanki.
A total of 5,001 samples were collected as part of the study, out of which 32 samples were rejected for various reasons and results were available for 4,969 samples – 2,354 males and 2,615 females, he said.
Out of these, 4,056 samples tested positive for antibodies against SARS-CoV-2, giving a positivity of 81.63 per cent, said an AMC report.
“A total of 1,938 males demonstrated the presence of antibodies, giving the positivity of 82.33 per cent, while 2,118 females, which comes to 80.99 per cent, had antibodies. Thus, the seropositivity is higher among males as compared to females,” the report stated.
The report said more than 80 percent of the population had antibodies against COVID-19 on account of their past infection, vaccination or both.
Of the total 2,887 persons in the sample size who did not have a history of coronavirus infection and who were not vaccinated yet, antibodies were found in 2,216 persons, which comes to 76.76 percent, the lowest in the entire sample.
On the other side, out of 158 persons who had both COVID-19 in the past and took two doses of vaccines, 154 persons, which comes to 97.47 percent, had antibodies, the report said.
Moreover, antibodies were found in 164 out of a total 173 persons (94.80 pc), who had COVID-19 in the past but took only one vaccine dose (when the survey was underway), it said.
Among the non-vaccinated, those who were infected with COVID-19 had higher seropositivity (81.93 per cent) than those without any history of the viral disease (76.76 pc), the report stated.
Among the vaccinated persons also, those with COVID-19 infection had higher seropositivity as compared to those without any history of the respiratory illness, it said.
Even for both these groups, individuals with two doses of vaccine had higher seropositivity than those with a single dose, it said.
“A majority of the vaccinated population in our sample were vaccinated with Covishield vaccine. Although there are very few who were vaccinated with Covaxin in our sample, people with Covaxin have slightly higher seropositivity as compared to Covishield,” said the survey.
“Considering the dose of vaccine received, those without any dose of vaccine have seropositivity of 77.04 percent, those with one dose have seropositivity of 86.06 percent, whereas those with 2 doses of vaccine have seropositivity of 94.22 percent. Thus, the seropositivity increases as the COVID-19 vaccine dose increases’ said the report.
As of May 2021, the study estimates 81.63 percent seropositivity for antibodies against SARS-CoV2 in general population of Ahmedabad, it said.
The available data is insufficient ‘to comment on the status of herd immunity for the entire city’, the report said.
”’Looking at higher seropositivity among vaccinated & higher seropositivity with completion of both the doses, further large-scale COVID-19 vaccination for the remaining & incompletely vaccinated population is strongly recommended for complete control over the pandemic situation,” the report said.
